It was noted in the March Pharmaceutical Schedule Update that Mylan, the supplier of doxepin hydrochloride capsules, had notified PHARMAC that ANTEN CAPSULES have been discontinued internationally by their manufacturer.

Stock remains available at present so there is no immediate cause for concern. However you will need to discuss with patients as we move closer to stock being depleted and delisting which will occur at varying times as follows:-

Anten Cap 10 mg 100                   Pharmacode 589209                                         Anticipated stock depletion July 2019                                   Delisting 1 January 2020

Anten Cap 25 mg 100                   Pharmacode 348554                                       Anticipated stock depletion November 2019                      Delisting 1 April 2020

Anten Cap 50 mg 100                   Pharmacode 348570                                          Anticipated stock depletion November 2019                      Delisting 1 May 2020

Anticipated stock depletion is based on current sales rates.

There is no other brand registered in New Zealand.

An Endorsement has been placed on doxepin hydrochloride, effective 1 March 2019 meaning no new patients can be initiated on doxepin capsules.

We thank you in anticipation of your ongoing support.

About The Author